Hepatitis B Treatment Market is expected to reach USD 5.9 billion by 2030 | Bristol-Myers Squibb, Gilead Sciences, Inc., GlaxoSmithKline

Global Hepatitis B Treatment Market reached USD 4.4 billion in 2022 and is expected to reach USD 5.9 billion by 2030 growing with a CAGR of 3.8% during the forecast period 2024-2031.

Hepatitis B Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/hepatitis-b-treatment-market?sg

Hepatitis B is a viral infection that causes inflammation of the liver. While it may begin as a mild condition, it can develop into a chronic, lifelong infection in some cases. Over time, persistent liver inflammation can lead to severe complications such as cirrhosis and liver failure. Notably, Hepatitis B can cause significant harm even without noticeable symptoms.

Treatment varies based on factors such as age, overall health, disease progression, and existing liver conditions. The primary goals are to control viral replication, minimize liver damage, and prevent further disease progression.

Preventive measures, including vaccination and Hepatitis B immune globulin (HBIG), are highly effective in newborns when administered shortly after birth, ensuring a favorable prognosis and safe breastfeeding.

According to the World Health Organization (WHO), only about 25% of individuals with chronic Hepatitis B show active liver disease, and available treatments are most effective for this group. Current therapies fall into two main categories: immune modulators and antiviral drugs.

The global Hepatitis B market is expected to grow due to the increasing prevalence of the virus, rising clinical trials for new treatments, and the surge in sexually transmitted diseases worldwide.

List of the Key Players in the Hepatitis B Treatment Market: Bristol-Myers Squibb, Gilead Sciences, Inc., GlaxoSmithKline, Accord Healthcare Inc., Apotex Corp., Arbutus Biopharma, Arrowhead Pharma, Aurobindo Pharma Limited, Lupin Pharmaceuticals Inc., and Merck & Co. Inc.

Industry Development:

On November 02, 2022, Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) approved the supplemental new drug application (sNDA) for Vemlidy (tenofovir alafenamide) 25 mg tablets as a once-daily treatment for chronic hepatitis B virus (HBV) infection in pediatric patients 12 years of age and older with compensated liver disease.

On November 1, 2022, Arcturus Therapeutics Holdings Inc., a prominent company specializing in the development of messenger RNA medicines for infectious diseases and rare liver and respiratory diseases, announced a strategic partnership with CSL Seqirus, a global leader in vaccines. This collaboration encompasses research, development, manufacturing, and worldwide distribution of vaccines. CSL Seqirus possesses one of the largest influenza vaccine franchises globally. It operates as a division of CSL Limited.

Growth Forecast Projected:

The Global Hepatitis B Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Hepatitis B Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/hepatitis-b-treatment-market?sg

Segment Covered in the Hepatitis B Treatment Market:

By Type (Acute, Chronic)

By Treatment (Immune modulator Drugs, Antiviral Drugs, Vaccines, Surgery)

By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa)

Regional Analysis for Hepatitis B Treatment Market:

The regional analysis of the Hepatitis B Treatment Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

View our full report: https://www.datamintelligence.com/research-report/hepatitis-b-treatment-market?sg

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Hepatitis B Treatment market?

➠ Who are the leading manufacturers in the global Hepatitis B Treatment industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Hepatitis B Treatment industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Hepatitis B Treatment market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports:

Hepatitis B Vaccine Market - https://www.datamintelligence.com/research-report/hepatitis-b-vaccine-market?sg

Hepatitis Diagnostic Testing Market - https://www.datamintelligence.com/research-report/hepatitis-diagnostic-testing-market?sg

Hepatitis C treatment Market - https://www.datamintelligence.com/research-report/hepatitis-c-treatment-market?sg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.